home / stock / albo / albo quote
Last: | $44.15 |
---|---|
Change Percent: | -1.7% |
Open: | $44.9 |
Close: | $44.15 |
High: | $44.9 |
Low: | $43.99 |
Volume: | 1,241,282 |
Last Trade Date Time: | 03/02/2023 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$44.15 | $44.9 | $44.15 | $44.9 | $43.99 | 1,241,282 | 03-02-2023 |
$44.25 | $44.65 | $44.25 | $44.74 | $43.95 | 1,898,301 | 03-01-2023 |
$44.55 | $44.32 | $44.55 | $44.58 | $44.32 | 259,229 | 02-28-2023 |
$44.38 | $43.71 | $44.38 | $44.41 | $43.56 | 260,616 | 02-27-2023 |
$43.61 | $43.56 | $43.61 | $43.875 | $43.53 | 182,962 | 02-24-2023 |
$43.59 | $43.61 | $43.59 | $43.83 | $43.305 | 240,800 | 02-23-2023 |
$43.5 | $43.77 | $43.5 | $44.135 | $43.48 | 806,302 | 02-22-2023 |
$43.76 | $43.83 | $43.76 | $43.94 | $43.515 | 2,510,333 | 02-21-2023 |
$43.73 | $44.15 | $43.73 | $44.15 | $43.64 | 1,646,909 | 02-20-2023 |
$43.73 | $44.15 | $43.73 | $44.15 | $43.64 | 1,646,909 | 02-17-2023 |
$44.06 | $44.15 | $44.06 | $44.2 | $43.95 | 545,805 | 02-16-2023 |
$44.18 | $44.2 | $44.18 | $44.26 | $44.12 | 496,124 | 02-15-2023 |
$44.29 | $44.16 | $44.29 | $44.47 | $44.14 | 228,869 | 02-14-2023 |
$44.19 | $44.17 | $44.19 | $44.28 | $44.02 | 307,306 | 02-13-2023 |
$44.33 | $44.2 | $44.33 | $44.47 | $43.92 | 487,038 | 02-10-2023 |
$44.16 | $44.31 | $44.16 | $44.55 | $44.02 | 222,793 | 02-09-2023 |
$44.23 | $44.52 | $44.23 | $44.55 | $44.15 | 234,002 | 02-08-2023 |
$44.59 | $44.46 | $44.59 | $44.74 | $44.4 | 178,183 | 02-07-2023 |
$44.59 | $44.8 | $44.59 | $45.13 | $44.38 | 226,538 | 02-06-2023 |
$44.95 | $44.15 | $44.95 | $45.23 | $44.15 | 511,136 | 02-03-2023 |
News, Short Squeeze, Breakout and More Instantly...
Albireo Pharma Inc. Company Name:
ALBO Stock Symbol:
NASDAQ Market:
Bylvay (odevixibat) granted Priority Review by U.S. FDA ASSERT study demonstrated efficacy of Bylvay in pruritus, bile acids and sleep with a low drug-related diarrhea rate in Alagille patients Approval in second indication would more than double Bylvay market oppo...
NEW YORK, NY / ACCESSWIRE / February 9, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Trean Insurance Group, Inc. (NASDA...
NEW YORK, NY / ACCESSWIRE / February 8, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Oak Street Health, Inc. (NYSE:OSH)'s ...